The multi-state operator expanded its footprint in a huge market.
Although it won't be able to sell recreational marijuana, that might change if a public vote is taken next year.
Marijuana company Curaleaf (OTC: CURLF) is expanding its presence in a potentially massive market, a move that resonated with investors on Thursday. That, plus a new weed reform resolution filed in the U.S. Congress, helped push the multi-state operator's (MSO) stock price up by 9% that trading session.
After market close Wednesday, Curaleaf announced it had opened a new dispensary in Cape Canaveral, Florida. The store is the 70th Curaleaf outlet in the state, which ranks No. 3 in terms of population in the country, and No. 5 in terms of gross domestic product (GDP).
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »
Image source: Getty Images.
The Sunshine State might soon become a much hotter pot market. At the moment, only medical marijuana is permitted for sale and consumption. However, an initiative to get a recreational weed measure on the ballot next year is making significant progress.
Separately, Democrats in the U.S. House of Representatives have submitted a resolution that mandates equity throughout the industry. It also calls for the current presidential administration to leverage its "voice, vote, and influence" to sway the United Nations toward a more lenient stance on the drug.
One dispensary in Florida and a cautious new congressional resolution (essentially a modified version of a previous effort) by the minority party in the House won't move the needle for Curaleaf. Or, for that matter, the wider marijuana industry.
And yet, both are signs that the broader effort to essentially legalize marijuana nationwide is ongoing and backed by determined, influential people. Little will change for the prospects of ever-struggling weed companies like Curaleaf until de facto legalization occurs.
Before you buy stock in Curaleaf, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Curaleaf wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $560,649!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,100,862!*
Now, it’s worth noting Stock Advisor’s total average return is 998% — a market-crushing outperformance compared to 194% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of December 1, 2025
Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.